ClinicalVentricular TachycardiaReappraisal of electrocardiographic criteria for localization of idiopathic outflow region ventricular arrhythmias
Introduction
The right ventricular outflow tract (RVOT) and left ventricular (LV) outflow region are common sites of origin (SOOs) for idiopathic ventricular arrhythmias (VAs)1 that can be successfully treated using catheter ablation.2,3 Multiple electrocardiographic (ECG) criteria to differentiate between VAs that arise from the RVOT and the LV outflow region have been described.4, 5, 6, 7, 8, 9, 10, 11 Additional ECG features have also been reported to localize VAs to a specific aortic sinus of Valsalva (ASV) or the right-left ASV commissure.12, 13, 14 ECG-guided localization of outflow region VAs has important procedural implications with regard to vascular access, catheter selection, anticoagulation administration, procedure time, and complication risks.4,15, 16, 17 The accuracy of ECG criteria may be limited by factors including the attitudinal position of the outflow regions in the chest cavity, lead position, chest wall deformities, and preferential conduction.6,18,19 In this study, we sought to reappraise previously reported ECG criteria and determine their accuracy in predicting the successful site of ablation of idiopathic VAs with a left bundle branch block (LBBB), inferior axis morphology.
Section snippets
Study population
The subjects of this retrospective study comprised 101 patients who had undergone catheter ablation of idiopathic VAs (85 [84%] presenting as premature ventricular complexes (PVCs) and 17 [16%] as sustained or nonsustained focal ventricular tachycardia) arising from the RVOT or ASV with a LBBB, inferior axis morphology at a single institution between June 2014 and June 2018. Baseline demographic data were collected by chart abstraction. The study was approved by the Institutional Review Board
Clinical characteristics
One hundred one patients (mean age 52 ± 16 years; range 22–90 years; 54 women [53%]) who underwent successful CA of 109 idiopathic outflow region VAs comprised the study population. Of the 109 VAs, 38 (35%) were successfully ablated from the ASV and 71 (65%) were successfully ablated from the RVOT. Among the 71 patients in the RVOT group, ablation was most commonly performed below the pulmonic valve (77%). Ablation above the pulmonic valve and on both sides of the valve was performed in 7% and
Discussion
In this study, we report the utility of reported ECG criteria for localization of idiopathic outflow region VAs with a LBBB, inferior axis morphology. The main findings of this study include the following: (1) the current published ECG criteria to differentiate ASV from RVOT VAs have limited discriminative ability, with positive predictive values ranging between 42% and 75%; (2) among the ECG criteria assessed, the V2S/V3R index had the largest ROC AUC; and (3) morphological criteria for
Conclusion
Our study of previously reported ECG criteria to differentiate the SOO of VAs between the ASV and the RVOT and localize ASV VAs to a particular sinus suggests that these criteria have a limited accuracy. Many factors such as variability in the proximity of the RVOT and ASV, attitudinal position of the outflow regions in the chest cavity, ablation approach, and ECG lead positioning contribute to the limitations of the ECG to precisely localize the SOO of outflow region VAs.
References (30)
- et al.
Radiofrequency catheter ablation for management of symptomatic ventricular ectopic activity
J Am Coll Cardiol
(1995) - et al.
The V2 transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin
J Am Coll Cardiol
(2011) - et al.
Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias
Heart Rhythm
(2011) - et al.
Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation
J Am Coll Cardiol
(2002) - et al.
Electrocardiographic characteristics of ventricular arrhythmias originating from the junction of the left and right coronary sinuses of Valsalva in the aorta: the activation pattern as a rationale for the electrocardiographic characteristics
Heart Rhythm
(2008) - et al.
Electrocardiographic and electrophysiologic features of ventricular arrhythmias originating from the right/left coronary cusp commissure
Heart Rhythm
(2010) - et al.
Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation
J Am Coll Cardiol
(2008) - et al.
Outflow tract tachycardia with R/S transition in lead V3: six different anatomic approaches for successful ablation
J Am Coll Cardiol
(2005) - et al.
Effect of electrocardiographic lead placement on localization of outflow tract tachycardias
Heart Rhythm
(2012) - et al.
Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp
J Am Coll Cardiol
(2007)
Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva
Heart Rhythm
Impact of earliest activation site location in the septal right ventricular outflow tract for identification of left vs right outflow tract origin of idiopathic ventricular arrhythmias
Heart Rhythm
Evaluation of the electrocardiographic transitional zone by cardiac computed tomography
J Electrocardiol
Catheter ablation of arrhythmias originating from the left ventricular outflow tract
JACC Clin Electrophysiol
Modified precordial lead R-wave deflection Interval predicts left- and right-sided idiopathic outflow tract ventricular arrhythmias
JACC Clin Electrophysiol
Cited by (0)
Funding sources: The authors have no funding sources to disclose.
Disclosures: Dr Cheung has received consulting fees from Abbott and Boston Scientific and fellowship grant support from Abbott, Biosense, and Boston Scientific. The rest of the authors report no conflicts of interest.